Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
13 Febbraio 2024 - 8:30PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. 1)*
Oncosec Medical Incorporated
(Name
of Issuer)
Common Stock, $0.0001 par value
(Title
of Class of Securities)
68234L405
(CUSIP
Number)
December
31, 2023
(Date
of Event which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐
Rule 13d-1(b)
☒
Rule 13d-1(c)
☐
Rule 13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a
prior cover page.
The
information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
CUSIP
No. 68234L405
| 1. |
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
SZOP
Multistrat LP |
| 2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)
☐
(b)
☒ |
| 3. |
SEC
USE ONLY
|
| 4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5. |
SOLE
VOTING POWER
0 |
| 6. |
SHARED
VOTING POWER
0* |
| 7. |
SOLE
DISPOSITIVE POWER
0 |
| 8. |
SHARED
DISPOSITIVE POWER
0* |
| 9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0* |
| 10. |
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ☐
|
| 11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0%* |
| 12. |
TYPE
OF REPORTING PERSON (see instructions)
PN |
CUSIP
No. 68234L405
| 1. |
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
SZOP
Multistrat Management LLC |
| 2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)
☐
(b)
☒ |
| 3. |
SEC
USE ONLY
|
| 4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5. |
SOLE
VOTING POWER
0 |
| 6. |
SHARED
VOTING POWER
0* |
| 7. |
SOLE
DISPOSITIVE POWER
0 |
| 8. |
SHARED
DISPOSITIVE POWER
0* |
| 9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0* |
| 10. |
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ☐
|
| 11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0%* |
| 12. |
TYPE
OF REPORTING PERSON (see instructions)
IA,
OO |
CUSIP
No. 68234L405
| 1. |
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Antonio
Ruiz-Gimenez |
| 2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)
☐
(b)
☒ |
| 3. |
SEC
USE ONLY
|
| 4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Spain |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5. |
SOLE
VOTING POWER
0 |
| 6. |
SHARED
VOTING POWER
0* |
| 7. |
SOLE
DISPOSITIVE POWER
0 |
| 8. |
SHARED
DISPOSITIVE POWER
0* |
| 9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0* |
| 10. |
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ☐
|
| 11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0%* |
| 12. |
TYPE
OF REPORTING PERSON (see instructions)
IN,
HC |
CUSIP
No. 68234L405
| 1. |
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Kerry
Propper |
| 2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)
☐
(b)
☒ |
| 3. |
SEC
USE ONLY
|
| 4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5. |
SOLE
VOTING POWER
0 |
| 6. |
SHARED
VOTING POWER
0* |
| 7. |
SOLE
DISPOSITIVE POWER
0 |
| 8. |
SHARED
DISPOSITIVE POWER
0* |
| 9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0* |
| 10. |
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ☐
|
| 11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0%* |
| 12. |
TYPE
OF REPORTING PERSON (see instructions)
IN,
HC |
CUSIP
No. 68234L405
Item
1.
| |
(a) |
Name
of Issuer
Oncosec Medical Incorporated (the “Issuer”) |
| |
|
|
| |
(b) |
Address
of Issuer’s Principal Executive Offices
820 Bear Tavern Road
Ewing, NJ 08628
|
Item
2.
| |
(a) |
Name
of Person Filing:
SZOP
Multistrat LP*
SZOP
Multistrat Management LLC*
Antonio
Ruiz-Gimenez*
Kerry
Propper* |
| |
|
|
| |
(b) |
Address
of the Principal Office or, if none, residence
17
State Street, Suite 2130
New
York, NY 10004 |
| |
|
|
| |
(c) |
Citizenship
SZOP
Multistrat LP – Delaware
SZOP
Multistrat Management LLC – Delaware
Antonio
Ruiz-Gimenez – Spain
Kerry
Propper – United States |
| |
|
|
| |
(d) |
Title
of Class of Securities
Common Stock, par value $0.0001 |
| |
|
|
| |
(e) |
CUSIP
Number
68234L405 |
Item
3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: N/A
CUSIP No. 68234L405
Item
4. Ownership.
Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
| |
(a) |
Amount
beneficially owned:
SZOP
Multistrat LP – 0*
SZOP
Multistrat Management LLC – 0*
Antonio
Ruiz-Gimenez – 0*
|
| |
|
Kerry Propper – 0* |
| |
(b) |
Percent
of class:
SZOP
Multistrat LP – 0.0%*
SZOP
Multistrat Management LLC – 0.0%*
Antonio
Ruiz-Gimenez – 0.0%*
Kerry
Propper – 0.0%* |
| |
|
|
| |
(c) |
Number
of shares as to which the person has: |
| |
(i) |
Sole
power to vote or to direct the vote
SZOP
Multistrat LP – 0*
SZOP
Multistrat Management LLC – 0*
Antonio
Ruiz-Gimenez – 0*
Kerry
Propper – 0* |
| |
|
|
| |
(ii) |
Shared
power to vote or to direct the vote
SZOP
Multistrat LP– 0*
SZOP
Multistrat Management LLC – 0*
Antonio
Ruiz-Gimenez – 0*
Kerry
Propper – 0* |
| |
|
|
| |
(iii) |
Sole
power to dispose or to direct the disposition of
SZOP
Multistrat LP – 0
SZOP
Multistrat Management LLC – 0
Antonio
Ruiz-Gimenez – 0
Kerry
Propper – 0 |
| |
|
|
| |
(iv) |
Shared
power to dispose or to direct the disposition of
SZOP
Multistrat LP – 0*
SZOP
Multistrat Management LLC – 0*
Antonio
Ruiz-Gimenez - 0*
Kerry
Propper - 0* |
Instruction.
For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).
*This
report shall not be deemed an admission that any reporting person or any other person is the beneficial owner of the securities reported
herein, or on previously filings, for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
The reporting persons expressly disclaim beneficial ownership of any security reported herein, or on previous filings, except to the
extent of each such reporting person’s pecuniary interest therein (if any).
CUSIP
No. 68234L405
Item
5. Ownership of Five Percent or Less of a Class.
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the following ☒.
Instruction.
Dissolution of a group requires a response to this item.
Item
6. Ownership of More than Five Percent on Behalf of Another Person.
N/A
Item
7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
N/A
Item
8. Identification and Classification of Members of the Group.
N/A
Item
9. Notice of Dissolution of Group.
N/A
Item
10. Certification.
By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction having that purpose or effect.
CUSIP
No. 68234L405
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
Dated:
February 13, 2024
| |
SZOP Multistrat LP
By: SZOP Multistrat Management LLC, its investment manager |
| |
|
|
| |
By: |
/s/
Antonio Ruiz-Gimenez |
| |
|
Antonio
Ruiz-Gimenez, Managing Member |
| |
|
|
| |
SZOP
Multistrat Management LLC |
| |
|
|
| |
By: |
/s/
Antonio Ruiz-Gimenez |
| |
|
Antonio
Ruiz-Gimenez, Managing Member |
| |
|
|
| |
Antonio
Ruiz-Gimenez |
| |
|
|
| |
By: |
/s/
Antonio Ruiz-Gimenez |
| |
|
Individually
|
| |
|
|
| |
Kerry
Propper |
| |
|
|
| |
By: |
/s/
Kerry Propper |
| |
|
Individually |
The
original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement
is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person,
evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however,
that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and
any title of each person who signs the statement shall be typed or printed beneath his signature.
Note.
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7
for other parties for whom copies are to be sent.
Attention.
Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).
Exhibit
I
CUSIP
No. 68234L405
JOINT
FILING STATEMENT
PURSUANT
TO RULE 13D-1(K)(1)
The
undersigned hereby consent and agree to the joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with
respect to the shares of Oncosec Medical Incorporated, together with any or all amendments thereto, when and if required. The
parties hereto further consent and agree to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule
13G, thereby incorporating the same into such Schedule 13G.
This
Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned
may mutually agree.
Dated:
February 13, 2024
| |
SZOP Multistrat LP
By: SZOP Multistrat Management LLC, its investment manager |
| |
|
|
| |
By: |
/s/
Antonio Ruiz-Gimenez |
| |
|
Antonio
Ruiz-Gimenez, Managing Member |
| |
|
|
| |
SZOP
Multistrat Management LLC |
| |
|
|
| |
By: |
/s/
Antonio Ruiz-Gimenez |
| |
|
Antonio
Ruiz-Gimenez, Managing Member |
| |
|
|
| |
Antonio
Ruiz-Gimenez |
| |
|
|
| |
By: |
/s/
Antonio Ruiz-Gimenez |
| |
|
Individually
|
| |
|
|
| |
Kerry
Propper |
| |
|
|
| |
By: |
/s/
Kerry Propper |
| |
|
Individually |
Grafico Azioni OncoSec Medical (CE) (USOTC:ONCSQ)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni OncoSec Medical (CE) (USOTC:ONCSQ)
Storico
Da Gen 2024 a Gen 2025
